Placenta-Derived Decidual Stromal Cells as Treatment for Haemorrhagic Cystitis in Patients Who Have Undergone Allogeneic Haematopoietic Stem Cell Transplantation (NCT02172963)

被引：0
|
作者：
Aronsson-Kurttila, W. [1 ]
Baygan, A. [1 ]
Remberger, M. [2 ]
Solders, M. [1 ]
Erkers, T. [1 ]
Nava, S. [1 ]
Khoein, B. [1 ]
Sadeghi, B. [1 ]
Kaipe, H. [1 ]
Ringden, O. [1 ]
机构：
[1] Karolinska Univ Hosp, Karolinska Inst, Lab Med Therapeut Immunol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P386
引用
收藏
页码：S319 / S319
页数：1
相关论文
共 48 条
  • [41] A boost of donor-derived CD34 selected peripheral blood cells without further conditioning in paediatric patients with poor graft function after allogeneic haematopoietic stem cell transplantation
    Giardino, S.
    Schmidt, M.
    Faraci, M.
    Lanino, E.
    Dini, G.
    Podesta, M.
    Terranova, P.
    Di Martino, D.
    Sabatini, F.
    Morreale, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S278 - S279
  • [42] Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naive CD4+ T Cells after Allogeneic Stem Cell Transplantation
    Gauthier, Simon-David
    Leboeuf, Dominique
    Manuguerra-Gagne, Renaud
    Gaboury, Louis
    Guimond, Martin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (10) : 1721 - 1731
  • [43] Isolation of donor derived CMV specific T-cells for the treatment of CMV disease in patients after in-vitro T-cell-depleted allogeneic stem cell transplantation
    Jedema, I
    Cox, LMP
    Meij, P
    Barge, RMY
    Willemze, R
    Falkenburg, JHF
    BONE MARROW TRANSPLANTATION, 2005, 35 : S26 - S26
  • [44] Frequent presence of donor-derived epithelial cells in buccal mucosa smears following allogeneic haematopoietic stem cell transplantation in 54 patients:: level not related to procedure, time after transplantation, or graft-versus-host disease
    Juliusson, G
    Frödin, U
    Bäckström, G
    Karlsson, K
    Malm, C
    BONE MARROW TRANSPLANTATION, 2004, 33 : S311 - S312
  • [45] Autologous-collected anti-cd19 chimeric antigen receptor (CAR) T cells for acute lymphocytic leukemia (ALL) and Non-Hodgkin's lymphoma (NHL) in children who have previously undergone allogeneic hematopoietic stem cell transplantation (HSCT).
    Lee, Daniel W.
    Shah, Nirali
    Stetler-Stevenson, Maryalice
    Sabatino, Marianna
    Richards, Kelly
    Delbrook, Cindy
    Kochenderfer, James N.
    Rosenberg, Steven A.
    Stroncek, David
    Mackall, Crystal L.
    Wayne, Alan S.
    CANCER RESEARCH, 2013, 73 (08)
  • [46] Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial
    Yamahara, Kenichi
    Hamada, Akiko
    Soma, Toshihiro
    Okamoto, Rika
    Okada, Masaya
    Yoshihara, Satoshi
    Yoshihara, Kyoko
    Ikegame, Kazuhiro
    Tamaki, Hiroya
    Kaida, Katsuji
    Inoue, Takayuki
    Ohsugi, Yuko
    Nishikawa, Hiroki
    Hayashi, Hiroshi
    Ito, Yoichi M.
    Iijima, Hiroaki
    Ohnishi, Shunsuke
    Hashimoto, Daigo
    Isoe, Toshiyuki
    Teshima, Takanori
    Ogawa, Hiroyasu
    Sato, Norihiro
    Fujimori, Yoshihiro
    BMJ OPEN, 2019, 9 (07):
  • [47] Allogeneic stem cell transplantation from HLA-haploidentical relatives as treatment for children with hematologic malignancy; A phase I/II study using mobilized peripheral blood progenitor cells (PBPCs) that have undergone CD34 selection followed by CD2 depletion.
    Yeager, AM
    Amylon, M
    Wagner, J
    Calderwood, S
    Anasetti, C
    Sender, L
    Jacobs, C
    Benyunes, M
    BLOOD, 1997, 90 (10) : 958 - 958
  • [48] Allogeneic stem cell transplantation from HLA-haploidentical donors as treatment for children with inborn errors; A phase I/II study using bone marrow or mobilized peripheral blood progenitor cells (PBPCs) that have undergone CD34 selection by micromagnetic beads method (Miltenyi device)
    Cavazzana-Calvo, M
    Jabado, N
    Casanova, JL
    Quartier, P
    Hacein-Bey, S
    Le Deist, F
    Fischer, A
    BLOOD, 1998, 92 (10) : 291A - 291A
12345